Notice of Plans to Allow 13 NIDA Program Announcements to Expire Without Renewal and Guidance to Applicants on how to Apply for Research Grants in Those Topic Areas

Notice Number: NOT-DA-17-065

Key Dates
Release Date: January 9, 2018

Related Announcements

PA-14-083
PA-14-084
PA-14-162
PA-14-163
PA-14-164
PA-15-001
PA-15-002
PA-15-003
PA-15-080
PA-15-081
PA-15-082
PA-15-110
PA-15-112

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The following Program Announcements will expire on January 8, 2018 and NIDA will not renew them.  NIDA remains interested in supporting research in each of the topic areas.  Information about these and other research topics will eventually be posted on the NIDA website.  Until that happens applicants are encouraged to apply for funding in these research areas using the appropriate "parent" Program Announcements.

Expiring Program Announcements are:

  • Neuroimmune Signaling and Function in Substance Use Disorders PA-14-083 (R21)
  • Neuroimmune Signaling and Function in Substance Use Disorders PA-14-084 (R01)
  • Effects of Cannabis Use and Cannabinoids on the Developing Brain PA-14-162 (R21)
  • Effects of Cannabis Use and Cannabinoids on the Developing Brain PA-14-163 (R01)
  • Effects of Cannabis Use and Cannabinoids on the Developing Brain PA-14-164 (R03)
  • Epidemiology of Drug Abuse   PA-15-001 (R21)
  • Epidemiology of Drug Abuse Effects of Cannabis Use and Cannabinoids on the Developing Brain PA-15-002 (R03)
  • Epidemiology of Drug Abuse    PA-15-003 (R01)
  • Drug Abuse Prevention Intervention Research  PA-15-080 (R21)
  • Drug Abuse Prevention Intervention Research  PA-15-081 (R03)
  • Drug Abuse Prevention Intervention Research     PA-15-082 (R01)
  • Gene-Environment Interplay in Substance Use Disorders   PA-15-110 (R01)
  • Gene-Environment Interplay in Substance Use Disorders    PA-15-112 (R21)

After January 8, 2018 applicants are encouraged to apply for funding in the above topic areas using one of the following already published "parent" FOAs.

  • R01 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484
  • R01 NIH Research Project Grant (Parent R01 Clinical Trial Required)  PA-18-345
  • R03 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) PA-18-488
  • R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-18-489
  • R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) PA-18-344

NIDA recommends that potential applicants contact one of the program officials below to discuss your research and to visit NIDA's website to find other FOAs of interest (https://www.drugabuse.gov/funding-app/pa). 

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:
Roger G Sorensen, Ph.D., MPA
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-3205 
Email: rsorense@mail.nih.gov

Da-Yu Wu, PhD 
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-4649
Email: wudy@mail.nih.gov

Marsha F. Lopez, Ph.D., M.H.S. 
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504 
Email: lopezmar@nida.nih.gov

Bethany Deeds, PhD, MA
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504 
Email: deedsb@nida.nih.gov

Naimah Weinberg, M.D. 
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1908
Email: nw46w@nih.gov